INS and diabetic retinopathy: We also studied the loading and release of peptide (insulin), a frequently used drug in diabetic retinopathy and convenient for light‐controlled drug release applications.[41] Its larger molecular size of ≈3 nm makes larger pore sizes on the COFs desirable to allow for an efficiently encapsulated loading.